Erika Hooker

439 total citations
24 papers, 306 citations indexed

About

Erika Hooker is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Erika Hooker has authored 24 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Erika Hooker's work include Prostate Cancer Treatment and Research (8 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (3 papers). Erika Hooker is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (3 papers). Erika Hooker collaborates with scholars based in United States, Canada and Czechia. Erika Hooker's co-authors include Bruno Larrivée, Eun‐Jeong Yu, Yongfeng He, Zijie Sun, Vien Le, D. T. Johnson, Joseph Geradts, Christos Boutopoulos, Won Kyung Kim and Mark L. Gonzalgo and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Erika Hooker

23 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Hooker United States 11 122 85 41 39 35 24 306
Aditya Dutta United States 11 166 1.4× 88 1.0× 27 0.7× 27 0.7× 43 1.2× 22 374
Junichi Sano Japan 12 77 0.6× 56 0.7× 53 1.3× 11 0.3× 13 0.4× 37 354
Hideaki Suzuki Japan 12 116 1.0× 91 1.1× 129 3.1× 12 0.3× 11 0.3× 30 479
Xian Yu China 10 65 0.5× 43 0.5× 32 0.8× 62 1.6× 12 0.3× 20 321
Aaron I. Weiner United States 11 218 1.8× 176 2.1× 119 2.9× 48 1.2× 22 0.6× 16 557
Seppe Cambier Belgium 6 120 1.0× 37 0.4× 42 1.0× 18 0.5× 24 0.7× 9 460
Lakshman Chelvarajan United States 13 139 1.1× 26 0.3× 56 1.4× 24 0.6× 15 0.4× 20 336
Deborah Kienhöfer Germany 12 218 1.8× 58 0.7× 25 0.6× 36 0.9× 14 0.4× 14 623
Matthew L. Hillestad United States 13 424 3.5× 28 0.3× 34 0.8× 12 0.3× 7 0.2× 23 557

Countries citing papers authored by Erika Hooker

Since Specialization
Citations

This map shows the geographic impact of Erika Hooker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Hooker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Hooker more than expected).

Fields of papers citing papers by Erika Hooker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Hooker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Hooker. The network helps show where Erika Hooker may publish in the future.

Co-authorship network of co-authors of Erika Hooker

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Hooker. A scholar is included among the top collaborators of Erika Hooker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Hooker. Erika Hooker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Popović, Natalija, Erika Hooker, A Barabino, et al.. (2021). COCO/DAND5 inhibits developmental and pathological ocular angiogenesis. EMBO Molecular Medicine. 13(3). e12005–e12005. 5 indexed citations
2.
Hooker, Erika, et al.. (2020). Diabetic Kidney Disease, Endothelial Damage, and Podocyte-Endothelial Crosstalk. Kidney Medicine. 3(1). 105–115. 50 indexed citations
3.
He, Yongfeng, Jiaqi Mi, Erika Hooker, et al.. (2020). Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis. Oncogene. 39(16). 3276–3291. 13 indexed citations
4.
Le, Vien, Yongfeng He, Erika Hooker, et al.. (2020). Loss of androgen signaling in mesenchymal sonic hedgehog responsive cells diminishes prostate development, growth, and regeneration. PLoS Genetics. 16(1). e1008588–e1008588. 20 indexed citations
5.
Hooker, Erika, et al.. (2020). Drop-on-demand cell bioprinting via Laser Induced Side Transfer (LIST). Scientific Reports. 10(1). 9730–9730. 31 indexed citations
6.
He, Yongfeng, D. T. Johnson, Julie Yang, et al.. (2019). Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate. Oncogene. 38(38). 6507–6520. 8 indexed citations
7.
Le, Vien, Eun‐Jeong Yu, Erika Hooker, et al.. (2019). The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression. PLoS Genetics. 15(10). e1008451–e1008451. 23 indexed citations
8.
Yu, Eun‐Jeong, Julie Yang, Yongfeng He, et al.. (2019). Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate. PLoS ONE. 14(1). e0211153–e0211153. 4 indexed citations
9.
Yu, Eun‐Jeong, Yongfeng He, Erika Hooker, et al.. (2019). A pivotal role of androgen signaling in Notch-responsive cells in prostate development, maturation, and regeneration. Differentiation. 107. 1–10. 6 indexed citations
10.
Mi, Jiaqi, Won Kyung Kim, Erika Hooker, et al.. (2019). Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin–mediated prostatic tumorigenesis. Journal of Biological Chemistry. 295(2). 631–644. 7 indexed citations
11.
He, Yongfeng, Erika Hooker, Eun‐Jeong Yu, et al.. (2018). Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells. Oncogene. 38(13). 2337–2350. 14 indexed citations
12.
Mi, Jiaqi, Erika Hooker, Hong Zeng, et al.. (2018). Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate. Journal of Biological Chemistry. 293(52). 20123–20136. 11 indexed citations
13.
Yu, Eun‐Jeong, Erika Hooker, D. T. Johnson, et al.. (2017). LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis. PLoS ONE. 12(3). e0174357–e0174357. 14 indexed citations
14.
Hooker, Erika, et al.. (2017). Binding and inhibition of the ternary complex factor Elk-4/Sap1 by the adapter protein Dok-4. Biochemical Journal. 474(9). 1509–1528. 3 indexed citations
15.
Johnson, D. T., Erika Hooker, Richard Luong, et al.. (2016). Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice. PLoS ONE. 11(2). e0148851–e0148851. 24 indexed citations
16.
Hooker, Erika, et al.. (2015). Identification of Tpr and α-actinin-4 as two novel SLK-interacting proteins. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(10). 2539–2552. 7 indexed citations
17.
Hooker, Erika, Cindy Baldwin, & Serge Lemay. (2012). New insights into Dok-4 PTB domain structure and function. Biochemical and Biophysical Research Communications. 427(1). 67–72. 7 indexed citations
18.
Baldwin, Cindy, et al.. (2011). Basal and Src kinase‐mediated activation of the EphA2 promoter requires a cAMP‐responsive element but is CREB‐independent. Journal of Cellular Biochemistry. 112(5). 1268–1276. 3 indexed citations
19.
Weber, Alvin F., Roger D. Moon, D. K. Sorensen, et al.. (1988). Evaluation of the stable fly (Stomoxys calcitrans) as a vector of enzootic bovine leukosis. American Journal of Veterinary Research. 49(9). 1543–1549. 29 indexed citations
20.
Weber, Alvin F., et al.. (1987). In vitro viral expression as a criterion for development of control procedures for enzootic bovine leukosis. American Journal of Veterinary Research. 48(6). 899–903. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026